Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation
Background: Obesity and circadian rhythm disruption are significant global health concerns, contributing to an increased risk of metabolic disorders. Both adipose tissue and circadian rhythms play critical roles in maintaining energy homeostasis, and their dysfunction is closely linked to obesity. T...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Biomedical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2319417025000046 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|